History of the Drug Trust
In 1987, the eighteen largest drug firms were ranked as follows:
- Merck (U.S.) $4.2 billion in sales.
- Glaxo Holdings (United Kingdom) $3.4 billion.
- Hoffman LaRoche (Switzerland) $3.1 billion.
- Smith U.S. Kline Beckman ($2.8 billion).
- $2.7 billion Ciba-Geigy (Switzerland).
- Pfizer (U.S.) $2.5 billion, despite Standard & Poor’s reporting $4 billion in sales.
- Hoechst A. G. ($2.5 billion; Standard & Poor’s lists its sales as $38 billion Deutschmarks) is a German company.
- $2.4 billion ($4.93 billion, according to Standard & Poor’s) American Home Products (U.S.).
- $2.3 billion ($3.72 billion Standard & Poor’s) Lilly (U.S.).
- Upjohn (U.S.) $2 billion.
- Squibb (U.S.) $2 billion.
- Johnson & Johnson (U.S.) $1.9 billion.
- Sandoz (Switzerland) $1.8 billion.
- Bristol Myers (U.S.) $1.6 billion.
- Beecham Group (United Kingdom) $1.4 billion (Standard & Poor’s estimates that the U.S. subsidiary’s sales totaled $1.4 billion, or $2.6 billion in total pounds sterling income).
- German company Bayer A. G. received $1.4 billion (Standard & Poor’s reports that the amount is $45.9 billion Deutschmarks).
- Syntex (U.S.) $1.1 billion.
- $1.1 billion (Standard & Poor’s lists the amount as $3.1 billion) for Warner Lambert (U.S.).
As a result, we discover that the United States continues to hold a commanding advantage in the manufacture and distribution of drugs. In 1987, prescription drug sales in the US increased by 12.5% to $27 billion.
Eleven of the top 18 companies are based in the US, followed by three in Switzerland, two in Germany, and two in the UK. Nutritionist T. J. Frye points out that the Rockefeller family controls the Drug Trust in the United States through a cartel arrangement with German company I. G. Farben.
When it actively participated in a cartel agreement with Standard Oil of New Jersey in the 1930s, I. G. Farben actually held the title of largest chemical company in Germany at the time. The Allied Military Government Similar to the famous court-ordered division of Standard Oil itself, it was split up into three companies after World War II as part of the “anti-cartel” goals of the time, with the Rockefellers maintaining a controlling interest in each of the new businesses. General William Draper of investment bankers Dillon Read announced the new decree in Germany from his office in the I. G. Farben building.
I. G. Farben would cease to exist going forward, and three new businesses would appear instead: Bayer from Leverkusen, BASF from Ludwigshafen, and Hoescht from close to Frankfort. Only ICI of England is bigger than the three spawns, which are all now bigger than the previous I. G. Farben. Over half of the products sold by these companies are exported. Shearman and Sterling, a Rockefeller law firm with William Rockefeller as a partner, represents BASF in the US partner.
Merck, the leading pharmaceutical company in the world, got its start as a pharmacy in Darmstadt, Germany, in 1668. John J. Horan, the company’s president, is a partner in both the Morgan Guaranty Trust and the J. P. Morgan Company. On May 10–12, 1985, he went to a Bilderberger gathering in Rye, New York. In 1953, Merck acquired Sharp & Dohme, a significant pharmaceutical company. Oscar Ewing, who played a key role in the government’s promotion of fluoridation for the Aluminum Trust, was the Merck company’s secretary at the time, and his office was located at One Wall Street in New York.
John T. Connor is one of the directors of Merck. He started his business career at Cravath, Swaine and Moore, the law firm that represented Kuhn, Loeb Company. Connor later joined the Office of Naval Research, served as the Secretary of the Navy’s special assistant from 1945 to 1947, and was president of Merck from 1967 to 1980. Connor also serves as a director of Warner Lambert, a rival pharmaceutical company, Capital Cities ABC, a media conglomerate, and Rockefeller’s Chase Manhattan Bank.
Each of the major pharmaceutical companies in the US has at least one director with close ties to the Rockefeller family or a Rothschild bank. John K. McKinley, the chief operating officer of Texaco, is another director of Merck. He also serves on the board of Manufacturers Hanover Bank, which Congressional records identify as a significant Rothschild bank.
The history of the pharmaceutical industry has always been one of fraud, preying on the fears of the uneducated and the credulous and exploiting people’s general anxieties about illness and mortality.
Goddard’s drops, a bone distillate that was marketed as a treatment for gout in England in 1673, is considered the grandfather of all nostrums. Tuscarora rice was offered for sale there in 1711 as a remedy for eating. Numerous “cures” have been discovered to be worse than the disease over the course of about four thousand years of the practice of writing prescriptions for pharmaceuticals. There is poison in physics, Shakespeare cautioned.
Atlanta’s well-known blood specialist, Dr. R. R. Dracke, also cautioned that
The following well-known medications—amidopyrene, dinitrophenol (a diet pill), novaldine, antipyrene, sulphanilamide, sedormid, and salvarsen—can poison the marrow in the bones, reduce the generation of white blood cells, and even be fatal when used as prescribed.
No acetanilid is safe, according to doctors, as all coal tar compounds are potent cardiac depressants.
Ascriptin is produced by Rorer Pharmaceuticals, and aspirin or aspirin-containing products should be used daily by men “to protect their heart,” according to television commercials. The claims that aspirin may prevent heart attacks in men have been stopped by the attorneys general of Texas and New York. Aspirin lowers fever and makes it challenging for a doctor to appropriately identify pneumonia.
Thalidomide was promoted as the “tranquilizer of the future” by the William S. Merrell Company, which later merged with Vick Chemical. It ensured that uncomfortable pregnancy symptoms would be under control. Unfortunately, moms who used it gave birth to babies who had flippers for limbs or legs or none. While carefully avoiding any treatment of American victims, 60 Minutes recently provided a 25-year update on English thalidomide victims.
The program highlighted the sufferers’ incredible bravery as they attempted to go about their regular lives, and the reporters appeared to struggle to contain their amusement at the bizarre creatures as they frantically struggled to maintain their upright position while rolling around like human eggs. A typical operation of CBS’ brand of “adversary journalism” would have been to shove a microphone in the face of the company’s chairman and demand to know why they didn’t realize this was a dangerous drug. However, CBS also avoided mentioning the names of the thalidomide manufacturers or distributors.
The pharmaceutical industry provides a significant portion of CBS’s advertising revenue, therefore they are not going to piss off their most loyal clients.
The anticholesterol medication MER/29, which was manufactured by William S. Merrell, was marketed as a breakthrough. It was quickly discovered that MER/29 was the culprit of “alligator skin,” eczema, hair color changes, and lack of sex drive.
Chloromycetin, developed by Parke-Davis, was hailed as the next great medicine in 1949. Many doctors were persuaded to administer it to their kids, who subsequently passed away from leukemia. Chloromycetin administration caused 75% of cases of aplastic anemia to be fatal. After being told the medication was safe by a Parke-Davis employee, Dr. H. A. Hooks of El Paso lost his seven and a half year old son.
A Washington grand jury indicted Richard Merrell and company chairman William S. Merrell in December 1963 for providing the FDA with false information regarding MER/29. They entered a “no contest” plea, and on June 4, 1964, they were given a $80,000 fine. Lawrence Walsh, a former federal judge from 1957 to 1960 who is now well known as the White Knight who is suing prominent personalities on nebulous claims of wrongdoing, served as the Parke-Davis defense attorney.
The American Medical Association exerted considerable pressure on Dr. Roger Hegeberg, Assistant Secretary of HEW, and the Secretary of HEW, Finch, after an oral contraceptive pill was discovered to cause severe reactions, claiming they were “over-emphasizing dangers.” As a result, the warning on the pill was reduced from 600 words to only 96 much milder words; this warning was then increased by Secretary Finch himself of April 7, 1970, to 120 words of warning, which was released personally
The drug was later discovered to cause cancer, heart attacks, and fatal blood clots. The AMA’s actions in this case stood in bizarre contrast to its harsh attacks on “quacks,” who it said were the true threats to the public, for many years.
Versed, an intravenous medication manufactured by Hoffman LaRoche, was discovered to have caused forty deaths in just two years. In his seminal book “Pills, Pesticides and Profits,” Richter mentions how a U.S. company named Velsicol marketed three million pounds of a pesticide called Phosvel (leptophos), despite the EPA never having given it its seal of approval.
It was shipped to thirty nations by Velsicol. The nervous system sustains severe damage as a result. It poisoned dozens of farmers and killed one hundred water buffalo in Egypt. A subsidiary of Chicago-based Northwest Industries, which generates $3 billion annually, Velsicol is run by longstanding rail tycoon Ben Heinemann, a trustee of the University of Chicago, and the First Chicago Corporation.
James E. Dovitt is a director of Northwest Industries as well as National Can, Hart, Schaffner and Marx, president of Mutual of New York, and director of MONY. The National Council of U.S. China Trade, Thomas S. Hyland, vice president of Standard & Poor’s, Gaylord Freeman, director of Baxter Travenol and Atlantic Richfield, James F. Bere, chairman of Borg-Warner, and directors of Abbott Laboratories, Time, Inc., Hughes Tool Company, and Field Enterprises are also directors of Northwest. William B. Graham, chairman of Baxter Travenol Drug Company, also a trustee of the University of
The U.S. Consumer Product Safety Commission outlawed TRIS, a fire-retardant chemical used in clothes, in 1977 following years of fervent advertising that claimed it would prevent thousands of children from dying in fires every year. The Third World received 2.4 million TRIS-treated clothing at that point. The FDA took dipyrene off the market in 1977. After it was discovered that it could cause serious blood disorders and interfere with white blood cell production, it was widely distributed in Latin America without any warning.
A nerve problem was discovered to be a side effect of the 1934 medicine cloquinol, manufactured by Ciba-Geigy (Batero Vioform and Mexon), which was used to treat amoebic dysentery. After 11,000 cases of SMON, subacute myelic optic neuropathy, 700 Japanese perished from taking it.
After then, Ciba-Geigy made a settlement payment to about 1500 victims and survivors. An painkiller that Hoechst sold was compared to aspirin, aminopyrein, and dipyrene. It was discovered to induce anemia and was outlawed in the US, but it was still available in Asia and Latin America. Additionally, chlorophenicol (chloromycetin) is still available in Asia and Latin America. Travelers are advised to use caution when using substances that are illegal in the United States and are available in other countries.
Aspartame (Nutrasweet), an artificial sweetener, has now overrun the American market. Although it has been criticized for causing brain convulsions, it brought in $750 million for its creators in 1987. More Congressional hearings have now been scheduled in the aspartame controversy, which has lasted thirteen years.
Burroughs Wellcome’s breakthrough AIDS medication, AZT, is expected to bring in millions of dollars. According to reports, it can extend an AIDS patient’s life from six months to two years. This company is controlled by the Wellcome Trust, whose board of directors includes Lord Franks, a director of the Rockefeller Foundation.
There is still a sizable market for tranquilizers. In addition to Librium, Limbitrol, Marplan, Noludar, Tractan, Clonpin, and Dalmane, Roche Labs (Hoffman LaRoche) continues to promote Valium, its top seller. The cancer treatment drug Matulane is also produced by Roche. Leukopenia, anemia, and thrompenia are the adverse effects of this medication, which also causes bleeding, leukemia, nausea, vomiting, stomatitis, dysphagia, diarrhea, discomfort, chills, fever, sweating, sleepiness, and dysphagia.
A practitioner of alternative medicine who ever dared to sell such a substance to the general public would face a life sentence in prison. We are all aware of the harm quacks may do to your health.
Dr. Bruce Medd, the medical director of Roche, welcomes these medications as gifts to humanity. Pay attention to his rhapsodies,
“In contrast to quackery, which has neither been scientifically examined nor verified, Roche goods are synonymous with excellence and effectiveness. Roche joins the fight against health fraud and dubious medicine.
The Office of Technology Assessment of the U.S. Government reports that, in spite of Dr. Medd’s claims, 95% of the medications currently available have not been shown to be effective. In fact, this author has never heard of any “quack” treatment producing even a small percentage of the negative side effects as those induced by Matulane, Dr. Medd’s prized creation, as described above.
Smith, Kline Beck-man is another company that sells “proven” medications. The company got its initial millions by selling the substance known as “speed” through doctor prescriptions, as well as the infamous Dexedrine and Dexamil. Executives at Smith, Kline Beckman have admitted to covering up 36 deaths and cases of serious kidney damage in patients taking their drug Selocrin, which was ultimately taken off the market, according to 34 charges.
Eli Lilly of Indiana and Smith Kline Corporation of Philadelphia pleaded guilty to criminal charges of failing to immediately notify the FDA about deaths and serious injuries to persons using their pharmaceuticals, according to Dr. Sidney M. Wolfe’s Health Letter from July 1986. Before it was pulled off the market due to negative effects, the arthritis medication Oraflex by Lilly had been on the market for three months and had been taken by 600,000 Americans. 300,000 prescriptions for Smith Kline’s high blood pressure drug Selacryn were written in just eight months.
Despite deaths and negative side effects from Feldene (pyroxicam, an arthritic medication), Pfizer suppressed information from the FDA. It was discovered that McNeil’s Suprol, an oral analgesic licensed in 1985, damages the kidneys. The arthritis medication Orudis (jetoprofen) from Wyeth increased the prevalence of ulcers. The FDA granted approval for Hoechst’s antidepressant Merital (nomigensine) in December 1984, but it was forced off the market in January 1986 due to catastrophic side effects, including hemolytic anemia. In March 1986, Wellbutrin (buproprion), which had been discovered to cause seizures in female users, was taken off the market.
Even if studies in esteemed medical journals claim that the officially recognized “standard of care” medicine for treating colon cancer is based on the use of the exceedingly hazardous chemical 5-F-U, it nevertheless has a good track record. Because the American Cancer Society owns 50% of 5-F-U, it is still routinely utilized. Ritalin, a medicine created by Swiss company Ciba-Geigy, is finding an expanding market in the American public school system. Ritalin has somehow transformed into the main tool for managing “hyperactive” (read: healthy) schoolchildren.
ADD (attention deficiency disorder) was a new label coined by social workers that could be “managed” with Ritalin 20 mg tablets in sustained release capsules. Ritalin use has increased 97% since 1985, aided by the educational institution, which is inclined to add any drug or chemical to the teaching process. Students are threatened with immediate expulsion from school unless they take the medicine.
The Wall Street Journal reported on January 15, 1988, that concerned parents have brought many lawsuits against schools over the administration of Ritalin. The Georgia Board of Medical Examiners is currently investigating the rapidly increasing usage of Ritalin in the wealthy suburbs of Atlanta’s public schools. A student who is currently on trial for murder has admitted that Ritalin was part of his defense.
Pesticides continue to pose a greater threat than insects. The drug lindane (also known as Gammelin 20), which is made by the Rockefeller-associated company Hooker Chemical, causes leukemia, convulsions, convulsion-like symptoms, and dizziness. The FDA fought Shell Oil’s lindane-containing pesticide strips for many years.
Despite the fact that it has been proven that lindane can contaminate any food substance as well as any non-metal food container, these strips and other vaporizers are frequently used in restaurants. The Pesticides Regulator continued to permit their usage for a further sixteen years even though these testing were finished in 1953!
According to FDA reports, Vapone 3, the lindane formulation, is continuously released by Shell Chemical Company’s No Pest Strips.
They were expressly forbidden by the Agriculture Department from being used in meat processing plants, but the resourceful maker sold them to restaurants. The U.S. Public Health Service issued warnings about the dangers of using Shell No Pest Strips in elderly or young children’s bedrooms between 1965 and 1970.
Dr. Roy T. Hansberry, an executive of Shell Chemical, which supported Shell Development, was a member of the seven-person task group established by the Agricultural Department to investigate the processes for registering pesticides.
Shell has 250 pesticide products registered.
The unsigned memo was attached to Hansberry’s personal approval to participate in this task force.
According to their statement, “The Agricultural Registration Service does not have, or is aware of, any official business with, the persons, firms, or organizations with which Dr. Hansberry has other financial interests… which would conflict or represent a conflict of interest.”
Assistant health commissioner Dr. Mitchell A. Zaron also owned shares in Shell Oil and worked as a consultant for Shell Chemical. He published findings that allegedly proved Vapona to be so safe that it didn’t need any precautions for young children, the elderly, or anyone with medical conditions. He supported the usage of Vapona strips at a Public Health Service gathering.